Literature DB >> 21861005

Epidemiologic and clinical characteristics of pregnant women living with HIV/AIDS in a region of Southern Brazil where the subtype C of HIV-1 infection predominates.

Sandra Aparecida Manenti1, João Galato Júnior, Elizângela da Silva Silveira, Roberto Teixeira Oenning, Priscyla Waleska Targino de Azevedo Simões, Jeverson Moreira, Celine Maria Fochesato, Luís Fernando de Macedo Brígido, Rosângela Rodrigues, Pedro Roosevelt Torres Romão.   

Abstract

UNLABELLED: Southern Brazil has the highest prevalence rate of AIDS in the country and is the only region in the Americas where HIV-1 subtype C prevails.
OBJECTIVE: We evaluated the epidemiologic and clinical characteristics of pregnant women living with HIV/AIDS in the South region of Santa Catarina, Brazil.
METHODS: All pregnant women with HIV infection attending the obstetric outpatient clinic of Criciúma, State of Santa Catarina, in 2007 (n = 46) were invited to participate. Data of 36 eligible participants were obtained through a standardized questionnaire.
RESULTS: The great majority were young, with a steady partner, low family income, low education level and referring early first sexual intercourse. Many reported use of illicit non-injecting drugs (55.5%) and unprotected sex with partners that were HIV-positive (57.7%), injecting drug user (22.2%), male inmate (19.4%), truck driver (13.8%), with history of sexually transmitted disease (11.1%) or men who have sex with men (MSM) (2.8%). Most (66.7%) of the participants had their HIV diagnosis done during the pregnancy, 7 (19.4%) had a previous history of HIV mother-to-child transmission. Therapy based on highly active antiretroviral therapy (94%) was initiated at 19.3 weeks on average and 33% showed irregular antiretroviral adherence.
CONCLUSION: These results confirm previous data on HIV epidemiology in Brazil and suggest that the women partners' sexual behavior and unprotected sexual intercourse are important aspects of HIV epidemic. Additional efforts in education, prophylaxis and medication adherence are needed.

Entities:  

Mesh:

Year:  2011        PMID: 21861005

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  6 in total

1.  Reducing the risk of HIV infection during pregnancy among South African women: a randomized controlled trial.

Authors:  D L Jones; K Peltzer; O Villar-Loubet; E Shikwane; R Cook; S Vamos; S M Weiss
Journal:  AIDS Care       Date:  2013-02-25

2.  Sexual risk, serostatus and intimate partner violence among couples during pregnancy in rural South Africa.

Authors:  Karl Peltzer; Deborah Jones; Stephen M Weiss; Olga Villar-Loubet; Elisa Shikwane
Journal:  AIDS Behav       Date:  2013-02

Review 3.  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.

Authors:  Jean B Nachega; Olalekan A Uthman; Jean Anderson; Karl Peltzer; Sarah Wampold; Mark F Cotton; Edward J Mills; Yuh-Shan Ho; Jeffrey S A Stringer; James A McIntyre; Lynne M Mofenson
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

4.  HIV knowledge, disclosure and sexual risk among pregnant women and their partners in rural South Africa.

Authors:  Molatelo Elisa Shikwane; Olga M Villar-Loubet; Stephen M Weiss; Karl Peltzer; Deborah L Jones
Journal:  SAHARA J       Date:  2013

5.  Sexual HIV risk behaviour and associated factors among pregnant women in Mpumalanga, South Africa.

Authors:  Karl Peltzer; Gladys Mlambo
Journal:  BMC Pregnancy Childbirth       Date:  2013-03-04       Impact factor: 3.007

6.  Epidemiological and clinical profile of HIV-infected patients from Southwestern Goias State, Brazil.

Authors:  Regyane Ferreira Guimarães Dias; Luciana Oliveira Bento; Camila Tavares; Hélio Ranes Filho; Melisia Adelaide Cesário da Silva; Luciene Carneiro Moraes; Ana Amélia Freitas-Vilela; Marcos Lázaro Moreli; Ludimila Paula Vaz Cardoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.